Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder
- 1 May 2003
- Vol. 61 (5) , 1053-1058
- https://doi.org/10.1016/s0090-4295(02)02522-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Association of the Circulating Levels of the Urokinase System of Plasminogen Activation With the Presence of Prostate Cancer and Invasion, Progression, and MetastasisJournal of Clinical Oncology, 2007
- PREOPERATIVE PLASMA LEVELS OF INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR PREDICT DISEASE RECURRENCE AND SURVIVAL OF PATIENTS WITH BLADDER CANCERJournal of Urology, 2002
- Preoperative plasma levels of transforming growth factor ?1 strongly predict clinical outcome in patients with bladder carcinomaCancer, 2001
- CA 125 AS A MARKER OF TUMOR ACTIVITY IN ADVANCED UROTHELIAL MALIGNANCYJournal of Urology, 2001
- The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasisMedicinal Research Reviews, 2001
- Independent Prognostic Value of Serum Hepatocyte Growth Factor in Bladder CancerJournal of Clinical Oncology, 2000
- The plasminogen activation system in tumor growth, invasion, and metastasisCellular and Molecular Life Sciences, 2000
- Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to PrognosisJNCI Journal of the National Cancer Institute, 1999
- Longitudinal screening for prostate cancer with prostate-specific antigenPublished by American Medical Association (AMA) ,1996
- Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancerUrology, 1996